Internalization mechanisms of cell-penetrating peptides

Scholarly Works

• Kowalczyk, T.; Merecz-Sadowska, A.; Synowiec, E.; Śliwiński, T.; Piekarski, J.; Szemraj, J.; Mori, M.; Rijo, P.; Sitarek, P. The Production of Recombinant Azurin from Pseudomonas aeruginosa and Its Ability to Induce Apoptosis in Various Breast Cancer Cell Lines. International Journal of Molecular Sciences 2025, 26, 6188. doi:10.3390/ijms26136188
• Neves, A. R.; Vivès, E.; Boisguérin, P.; Quintela, T.; Costa, D. Circadian-Tuned Peptide Drug/Gene Co-Delivery Nanocomplexes to Enhance Glioblastoma Targeting and Transfection. International Journal of Molecular Sciences 2025, 26, 6130. doi:10.3390/ijms26136130
• Sun, M.; Yin, P.; Chen, S.; Wang, X. Intranasal Absorption Enhancement of Antidiabetic Therapeuticals by the Functional Peptide Segment of Latroeggtoxin-VI. Molecular pharmaceutics 2025. doi:10.1021/acs.molpharmaceut.5c00293
• Okafor, M.; Schmitt, D.; Ory, S.; Gasman, S.; Hureau, C.; Faller, P.; Vitale, N. The Different Cellular Entry Routes for Drug Delivery Using Cell Penetrating Peptides. Biology of the cell 2025, 117, e70012. doi:10.1111/boc.70012
• Umeno, T.; Takemoto, H.; Oba, M. Plasmid DNA delivery using arginine-rich cell-penetrating L/D-peptides containing α-aminoisobutyric acids. Organic & biomolecular chemistry 2025, 23, 5191–5196. doi:10.1039/d5ob00627a
• Datta, N. A Review on the Cell-Penetrating Peptides. Cell Engineering & Therapy Connect 2025, 1, 1. doi:10.69709/cellengc.2025.145023
• Liang, H.; Xing, Y.; Wang, K.; Zhang, Y.; Yin, F.; Li, Z. Peptides: potential delivery systems for mRNA. RSC chemical biology 2025, 6, 666–677. doi:10.1039/d4cb00295d
• Spiegel, S.; Joly, S.; Meli, I.; Chan, A.; Pernet, V. Modulation of antibody transport in the brain and spinal cord through the intranasal pathway. Neurotherapeutics : the journal of the American Society for Experimental NeuroTherapeutics 2025, e00606. doi:10.1016/j.neurot.2025.e00606
• Nguyen, C. T. G.; Meng, F. Unleashing the power of nucleic acid therapeutics through efficient cytosolic delivery. Journal of controlled release : official journal of the Controlled Release Society 2025, 383, 113774. doi:10.1016/j.jconrel.2025.113774
• Xu, L.; Small, J. M.; Hood, S. M.; Zhao, M.; Plough, L. V.; Wong, T.-T. Morpholino oligomer delivery via bath immersion for use in reverse genetic studies on the early development of eastern oysters (Crassostrea virginica). Aquaculture 2025, 600, 742261. doi:10.1016/j.aquaculture.2025.742261
• Baghirov, H. Mechanisms of receptor-mediated transcytosis at the blood-brain barrier. Journal of controlled release : official journal of the Controlled Release Society 2025, 381, 113595. doi:10.1016/j.jconrel.2025.113595
• Xiao, W.; Jiang, W.; Chen, Z.; Huang, Y.; Mao, J.; Zheng, W.; Hu, Y.; Shi, J. Advance in peptide-based drug development: delivery platforms, therapeutics and vaccines. Signal transduction and targeted therapy 2025, 10, 74. doi:10.1038/s41392-024-02107-5
• Herman, L.; Guagliardo, R.; Zamborlin, A.; Liu, Q.; Pérez-Gil, J.; De Smedt, S. C.; Raemdonck, K. Surfactant protein B-derived peptides as endosomal escape enhancers for pulmonary delivery of siRNA. Journal of controlled release : official journal of the Controlled Release Society 2025, 381, 113571. doi:10.1016/j.jconrel.2025.02.067
• Brouwer, C.; Welling, M. M.; Alwasel, S.; Boekhout, T. Potential health benefits of lactoferrin and derived peptides - how to qualify as a medical device?. Critical reviews in microbiology 2025, 1–25. doi:10.1080/1040841x.2025.2466465
• Matsuda, Y.; Ishizaki, T.; Uto, T.; Onoda, I.; Wong, R. W.; Takahashi, K.; Hirata, E.; Kuroda, K. Dual-Functionalized Zwitterionic Polymers for Cell Cryopreservation. Langmuir : the ACS journal of surfaces and colloids 2025, 41, 3888–3894. doi:10.1021/acs.langmuir.4c04014
• Pašalić, L.; Pem, B.; Jakas, A.; Čikoš, A.; Groznica, N.; Mlinarić, T.; Accorsi, M.; Mangiarotti, A.; Dimova, R.; Bakarić, D. Peptide-induced hydration of lipid bilayers modulates packing pattern and conformations of hydrocarbon chains – a potential pathway for peptide translocation?. Cold Spring Harbor Laboratory 2025. doi:10.1101/2025.02.04.636480
• Al Musaimi, O. FDA-Approved Antibacterials and Echinocandins. Antibiotics (Basel, Switzerland) 2025, 14, 166. doi:10.3390/antibiotics14020166
• Li, X.; Xu, J.; Yao, S.; Zhang, N.; Zhang, B.-T.; Zhang, Z.-K. Targeting Drug Delivery System to Skeletal Muscles: A Comprehensive Review of Different Approaches. Journal of cachexia, sarcopenia and muscle 2025, 16, e13691. doi:10.1002/jcsm.13691
• Wang, J.-H.; Cui, M.; Liu, H.; Guo, P.; McGowan, J.; Cheng, S.-Y.; Gessler, D. J.; Xie, J.; Punzo, C.; Tai, P. W. L.; Gao, G. Cell-penetrating peptide-grafted AAV2 capsids for improved retinal delivery via intravitreal injection. Molecular therapy. Methods & clinical development 2025, 33, 101426. doi:10.1016/j.omtm.2025.101426
• Biswas, A.; Periyasamy, K.; Maloverjan, M.; Porosk, L.; Arya, G.; Mehta, S.; Andla, H.; Raid, R.; Kisand, V.; Rätsep, M.; Wengel, J.; Rebane, A.; Pooga, M. Engineered PepFect14 analog for efficient cellular delivery of oligonucleotides. Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie 2025, 184, 117872. doi:10.1016/j.biopha.2025.117872

Explore citations to this article at